Pseudomyxoma peritonei - Neue Hoffnungen durch innovatives Behandlungskonzept

• 1 Alexander H R, Buel J F, Fraker D. Rationale and clinical status of continuous hyperthermic peritoneal perfusion for the treatment of peritoneal carcinomatosis.  PPO Updates. 1995;  9 - 9
• 2 Bankert R B, Eglimez N K, Hess S. Human-SCID Mouse chimeric models for the evaluation of anti-cancer therapies.  Trends in immunology. 2001;  22 386-393
• 3 Ceelen W P, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advancedintra-abdominal cancer.  Br J Surg. 2000;  87 006-1015
• 4 Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, Rougier P, Ducreux M. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.  Cancer. 2001;  92 71-76
• 5 Hinson F L, Ambrose N S. Pseudomyxoma peritonei.  Br J Surg. 1998;  85 1332-1339
• 6 Jähne J, Piso P, Schmoll E, Schmoll E, Sterzenbach H, Paul H, Pichlmayr R. Intraoperative (hypertherme) intraperitoneale Chemotherapie - Überlegungen und Aspekte zum sicheren intra- und postoperativen Umgang mit Zytostatika.  Langenbecks Arch Chir. 1997;  382 8-14
• 7 Piso P, Werner U, Bektas H, Bornscheuer A, Manns M P, Schlitt H J, Klempnauer J. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of appendiceal carcinoma.  Eur J Surg Oncol. 2001;  27 286-290
• 8 Sugarbaker P H. Peritonectomy procedures.  Ann Surg. 1995;  221 29- 42
• 9 Sugarbaker P H, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.  Ann Surg Oncol. 2000;  6 727-731
• 10 Zeidler R, Reisbach G, Wollenberg B, Lang S, Chaubal S, Schmitt B, Lindhofer H. Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing.  J Immunology. 1999;  163 1246-1252